Background Systemic sclerosis–associated interstitial lung disease (SSc-ILD) is a major clinical challenge with no effective treatments. It is also the leading cause of death in patients with systemic sclerosis. Thus, understanding its underlying molecular me…
1. Introduction
Systemic sclerosis (SSc) is a rare autoimmune disease, which is characterized by skin and organ fibrosis and vascular injury [1,2]. Interstitial lung disease (ILD) is a common clinic… [+62870 chars]
